Immunophenotypic characterisation of acute leukaemia after polycythemia vera. [PDF]
, 1993 Jesús María Hernández‐Rivas +7 more
openalex +1 more source
Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor [PDF]
, 1992 Chunhua Dai +5 more
openalex +1 more source
Current management strategies for polycythemia vera and essential thrombocythemia.
Blood reviews, 2020 P. Guglielmelli, A. Vannucchi
semanticscholar +1 more source
Patient-reported outcomes data from REVEAL at the time of enrollment (baseline): A prospective observational study of patients with polycythemia vera in the United States [PDF]
, 2018 Boccia, Ralph V +7 more
core +2 more sources
Recombinant interferon alpha in the treatment of polycythemia vera [letter; comment] [PDF]
, 1991 E Cacciola +5 more
openalex +1 more source
Treatment of Polycythemia Vera: Use of 32P Alone or in Combination With Maintenance Therapy Using Hydroxyurea in 461 Patients Greater Than 65 Years of Age [PDF]
, 1997 Y Najean, Jean‐Didier Rain
openalex +1 more source
Conflating polycythemia vera with essential thrombocytosis. [PDF]
Blood AdvSpivak JL.
europepmc +1 more source
Towards a molecular understanding of polycythemia rubra vera [PDF]
, 2000 Heike L. Pahl
openalex +1 more source
The role of a low erythropoietin level for the polycythemia vera diagnosis.
Blood Cells, Molecules & Diseases, 2020 Oleksandra Lupak +5 more
semanticscholar +1 more source